GLP-1 Receptor Agonist
GLP-1 receptor agonist. Extensively published in metabolic pathway research.
Semaglutide is a GLP-1 receptor agonist with a 94% amino acid sequence homology to native GLP-1. STEP-1 trial data (NEJM, 2021) showed 14.9% mean body weight reduction. It is the most studied GLP-1 analog in clinical research, with data across obesity, type 2 diabetes, and cardiovascular disease.
Store lyophilized at -20°C. Reconstituted in BAC water: refrigerate 2–8°C, use within 4–6 weeks.